脊椎ポンプ市場 - 世界の産業規模、シェア、動向、機会、予測、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

脊椎ポンプの世界市場は、2024年に4億135万米ドルと評価され、予測期間には6億8,940万米ドルに達すると予測され、2030年までのCAGRは9.41%です。

脊椎ポンプは、髄腔内ドラッグデリバリーシステムまたは単にポンプとしても知られ、脊髄内の脳脊髄液（CSF）に直接薬剤を標的送達するために使用される医療機器です。このドラッグデリバリーの方法は、中枢神経系への薬剤の正確かつ制御された投与を可能にし、特に疼痛管理や特定の病状の治療においていくつかの利点をもたらします。脊椎ポンプは、腰痛症、複合性局所疼痛症候群（CRPS）、神経障害性疼痛、がん性疼痛など、他の治療法に反応しない慢性疼痛や重症疼痛の管理によく使用されます。脊椎ポンプは、バクロフェンなどの筋弛緩剤を脊髄に直接投与することにより、多発性硬化症（MS）、脳性麻痺、脊髄損傷などの症状における重度の痙縮を管理することができます。また、ジストニア、特定の運動障害、膀胱、腸の機能障害、場合によっては精神疾患や難治性てんかんの治療にも使用されます。

主要な市場促進要因

技術の進歩

主要な市場課題

コスト抑制

主要市場動向

植え込み型ポンプの採用増加

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の脊椎ポンプ市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 用途別（悪性疼痛、非悪性疼痛、疼痛管理、痙性管理）
  • エンドユーザー別（代替ケアセンター、ASC、クリニック、病院、長期ケアセンター）
  • 企業別（2024年）
• 市場マップ

第6章 アジア太平洋の脊椎ポンプ市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の脊椎ポンプ市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の脊椎ポンプ市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の脊椎ポンプ市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの脊椎ポンプ市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の脊椎ポンプ市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 PESTEL分析

第16章 競合情勢

• Medtronic Plc.
• FlowonixMedical, Inc.
• Tricumed Medizintechnik GmbH
• Smith Group Plc
• Johnson & Johnson Private Limited
• Teleflex, Inc.
• Becton Dickinson & Co.
• DePuy Synthes Inc.

第17章 戦略的提言

第18章 調査会社について・免責事項

Global Spinal Pumps Market was valued at USD 401.35 Million in 2024 and is expected to reach USD 689.40 Million in the forecast period with a CAGR of 9.41% through 2030. A spinal pump, also known as an intrathecal drug delivery system or simply a pump, is a medical device used for the targeted delivery of medications directly into the cerebrospinal fluid (CSF) within the spinal cord. This method of drug delivery allows for precise and controlled administration of medications to the central nervous system, offering several advantages, particularly in pain management and the treatment of specific medical conditions. Spinal pumps are commonly used to manage chronic and severe pain conditions that are unresponsive to other treatments, such as failed back surgery syndrome, complex regional pain syndrome (CRPS), neuropathic pain, and cancer-related pain. Spinal pumps can help manage severe spasticity in conditions like multiple sclerosis (MS), cerebral palsy, and spinal cord injury by delivering muscle relaxants like baclofen directly to the spinal cord. Spinal pumps are also used to treat conditions such as dystonia, certain movement disorders, bladder, and bowel dysfunction, and, in some cases, psychiatric disorders and refractory epilepsy.

Key Market Drivers

Advancements in Technology

Modern spinal pumps are often programmable, allowing healthcare providers to adjust medication dosages and delivery rates remotely. This flexibility enables personalized pain management plans tailored to each patient's needs. Some spinal pumps offer micro-dosing capabilities, allowing for extremely precise drug delivery. This is particularly beneficial when patients require very low doses of medication or need highly controlled pain management. Advanced spinal pumps are equipped with continuous monitoring and data logging features. These capabilities enable healthcare providers to track the performance of the pump, medication usage, and patient responses over time. Spinal pumps can now be remotely monitored and adjusted using wireless or remote-control devices. Healthcare providers can make real-time adjustments to medication delivery without the need for in-person visits, improving patient convenience. Modern spinal pumps include integrated alarm systems that alert both healthcare providers and patients to any issues or anomalies, such as low medication levels or technical malfunctions. Battery technology has improved, leading to longer-lasting power sources for spinal pumps. This enhances the reliability of these devices and reduces the need for frequent battery replacements. Noise reduction technologies have been integrated into spinal pump designs, making them quieter and less noticeable to patients.

Key Market Challenges

Cost Containment

The upfront cost of acquiring and implanting a spinal pump system can be substantial. This includes the cost of the pump device itself, surgical implantation, hospitalization, and other associated expenses. High initial costs can be a barrier for healthcare facilities and patients. Many spinal pump systems deliver specialized medications that are often more expensive than oral equivalents. The ongoing cost of medications used in spinal pumps can be a financial burden, particularly for long-term therapy. Spinal pump systems require periodic refilling of medication reservoirs, typically every few weeks or months. These refilling procedures come with associated costs for healthcare facilities and patients. Surgical implantation of the spinal pump, as well as follow-up visits for adjustments and monitoring, can add to the overall cost of treatment. The utilization of healthcare resources, including surgical teams, anesthesiologists, pain management specialists, and nurses, contributes to the overall cost of spinal pump therapy. Healthcare facilities must allocate these resources effectively. Ensuring adequate reimbursement for spinal pump therapy is a complex process. It can involve negotiations with insurance providers and adherence to specific criteria for coverage, making it challenging for healthcare facilities and patients to secure financial support. Access to healthcare facilities and providers with expertise in spinal pump therapy may be limited in certain regions, leading to higher costs associated with travel and specialized care.

Key Market Trends

Rising Adoption of Implantable Pumps

Implantable pumps allow for highly precise and controlled drug delivery directly to the cerebrospinal fluid within the spinal cord. This targeted approach minimizes systemic side effects and maximizes the therapeutic effect of medications, making it particularly valuable in pain management and spasticity control. Implantable pumps are highly effective in managing chronic and severe pain conditions that are often refractory to other treatment methods. Patients with conditions like failed back surgery syndrome, complex regional pain syndrome (CRPS), and cancer-related pain benefit from better pain control and improved quality of life. The use of implantable pumps can reduce a patient's reliance on oral or systemic medications, particularly opioids. This is significant in the context of the opioid epidemic and concerns about opioid-related side effects and dependence. Implantable pumps allow for individualized treatment plans. Healthcare providers can adjust medication dosages, delivery rates, and schedules to meet each patient's specific needs, improving the overall quality of care. With implantable pumps, medication waste is minimized because drugs are delivered directly to the target site. This is an important consideration for healthcare cost containment and sustainability. Implantable pumps can provide long-term therapy for chronic conditions, reducing the need for frequent medication adjustments and improving patient adherence. Once implanted, these devices require less day-to-day attention from patients compared to external devices, such as transdermal patches or oral medications. This can lead to improved patient compliance and quality of life.

Key Market Players

• DePuy Synthes Inc.
• FlowonixMedical, Inc.
• Medtronic Plc
• Teleflex, Inc.
• Tricumed Medizintechnik GmbH
• Smith's Group Plc
• Johnson & Johnson Private Limited
• Becton & Dickinson Co.

Report Scope:

In this report, the Global Spinal Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spinal Pumps Market, By Application:

• Malignant Pain
• Non-Malignant Pain
• Pain Management
• Spasticity Management

Spinal Pumps Market, By End-User:

• Alternate Care Centers
• ASCs
• Clinics
• Hospitals
• Long Term Care Centers

Spinal Pumps Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
• Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spinal Pumps Market.

Available Customizations:

Global Spinal Pumps Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Spinal Pumps Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Application (Malignant Pain, Non-Malignant Pain, Pain Management, Spasticity Management)
  • 5.2.2. By End-User (Alternate Care Centers, ASCs, Clinics, Hospitals, Long Term Care Centers)
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. Asia Pacific Spinal Pumps Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Application
  • 6.2.2. By End-User
  • 6.2.3. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Spinal Pumps Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Application
      • 6.3.1.2.2. By End-User
  • 6.3.2. India Spinal Pumps Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Application
      • 6.3.2.2.2. By End-User
  • 6.3.3. Australia Spinal Pumps Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Application
      • 6.3.3.2.2. By End-User
  • 6.3.4. Japan Spinal Pumps Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Application
      • 6.3.4.2.2. By End-User
  • 6.3.5. South Korea Spinal Pumps Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Application
      • 6.3.5.2.2. By End-User

7. Europe Spinal Pumps Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Application
  • 7.2.2. By End-User
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spinal Pumps Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Application
      • 7.3.1.2.2. By End-User
  • 7.3.2. Germany Spinal Pumps Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Application
      • 7.3.2.2.2. By End-User
  • 7.3.3. Spain Spinal Pumps Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Application
      • 7.3.3.2.2. By End-User
  • 7.3.4. Italy Spinal Pumps Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Application
      • 7.3.4.2.2. By End-User
  • 7.3.5. United Kingdom Spinal Pumps Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Indication
      • 7.3.5.2.2. By Distribution Channel

8. North America Spinal Pumps Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Application
  • 8.2.2. By End-User
  • 8.2.3. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Spinal Pumps Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Application
      • 8.3.1.2.2. By End-User
  • 8.3.2. Mexico Spinal Pumps Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Application
      • 8.3.2.2.2. By End-User
  • 8.3.3. Canada Spinal Pumps Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Application
      • 8.3.3.2.2. By End-User

9. South America Spinal Pumps Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Application
  • 9.2.2. By End-User
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spinal Pumps Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Application
      • 9.3.1.2.2. By End-User
  • 9.3.2. Argentina Spinal Pumps Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Application
      • 9.3.2.2.2. By End-User
  • 9.3.3. Colombia Spinal Pumps Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Application
      • 9.3.3.2.2. By End-User

10. Middle East and Africa Spinal Pumps Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Application
  • 10.2.2. By End-User
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spinal Pumps Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Application
      • 10.3.1.2.2. By End-User
  • 10.3.2. Saudi Arabia Spinal Pumps Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Application
      • 10.3.2.2.2. By End-User
  • 10.3.3. UAE Spinal Pumps Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Application
      • 10.3.3.2.2. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Spinal Pumps Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. PESTLE Analysis

16. Competitive Landscape

• 16.1. Medtronic Plc.
  • 16.1.1. Business Overview
  • 16.1.2. Company Snapshot
  • 16.1.3. Products & Services
  • 16.1.4. Financials (In case of listed companies)
  • 16.1.5. Recent Developments
  • 16.1.6. SWOT Analysis
• 16.2. FlowonixMedical, Inc.
• 16.3. Tricumed Medizintechnik GmbH
• 16.4. Smith Group Plc
• 16.5. Johnson & Johnson Private Limited
• 16.6. Teleflex, Inc.
• 16.7. Becton Dickinson & Co.
• 16.8. DePuy Synthes Inc.

17. Strategic Recommendations

18. About Us & Disclaimer